DOUBLE
SIDES OF BIOLOGICAL SCIENCE
Biological science when
properly utilized can contribute positively to socio- economic development of any
given nation. It can play a great role in agriculture, health, environment and
industries and also provide goods and services to an ever growing global
population. This field of science has been used to increase crop yields,
improve quality and quantity of livestock and their products, develop
diagnostic tools for both animal and human health and exploit natures' flora
and fauna sustainably for socio-economic development. For instance, most
pharmaceutical companies all over the world use this field of science to
produce drugs and vaccines for infectious and no- infectious diseases. In
addition, environmental protection and sustainability is ensured through
application of biological sciences. On the other side, if not used well,
knowledge from biological science can be used for none peaceful purposes. In
the spirit of ensuring safe research and use of biological agents and toxins,
Biological and Toxin Weapons Convention (BTWC) was developed.
The BTWC bans the development,
production, stockpiling, acquisition and retention of microbial or other
biological agents or toxins, in types and in quantities that have no
justification for prophylactic, protective or other peaceful purposes. The
convention was simultaneously opened for signature in Moscow, Washington and
London in 1972 and entered into force in 1975.
Kenya acceded to the convention in 1976.
By 2012, the total number of States Parties to the Convention was 166 out
of which 29 were from Africa with 6 from
East Africa namely; Kenya, Uganda, Burundi, Ethiopia, Rwanda and Sudan. The
National Council for Science and Technology is the National Focal Point for the
BTWC in Kenya.
Article
IV of BTWC requires States Parties to take necessary national measures such as enactment
of national laws to prohibit and prevent the misuse of biological agents,
toxins, weapons, equipment and means of delivery within their territories; and Article
X states that States Parties should undertake to facilitate the fullest
possible exchange of equipment, materials and scientific and technological
information for the use of biological agents and toxins for peaceful purposes. Under the two articles, the Government of
Kenya has benefited through capacity building in research institutions and
institutions of higher learning; upgrading of laboratories, sensitization of
stakeholders and training of communication officers from various government
ministries and agencies in addition to finalization of the draft Biosciences
Policy and Biosciences Bill. Two Kenyans have been fully sponsored in the past
to attend the Meeting of States parties and the Seventh Review Conference of
the convention respectively.
The
fact that biological sciences research is crucial in Kenya should not be
underestimated. This is because such research can contribute heavily to
socio-economic development of the country. Kenya through its research
institutions such as KARI and KEMRI which have positively used biological
science knowledge generated through research to address national development
challenges such as food insecurity and human health.
In
KARI, research in biotechnology has played a significant role in improving the
quality and quantity of animals and increased crop production through breeding,
improved indigenous crops such as sorghum, sweet potatoes and cassava by their
fortification with Vitamin A Already,
farmers have started reaping the benefits of tissue cultured bananas through
increased yields and better prices in the local market in many regions in
Kenya. In animal production, research has led to development of disease
resistant breeds for increased milk and beef production.. Regionally, Kenya not
only boasts of having the best dairy breeds but also has developed through
biological research livestock vaccines such as Avivax, (anti-Newcastle virus
vaccine), Riftvax (Rift valley fever vaccine) and Rindervax (Rinderpest
vaccine) and Fowlvax (Fowl typhoid vaccine) among many others against common
livestock diseases and infections.
In
health, KEMRI has developed a fully fledged production unit that utilizes
findings from human research to develop innovative tools to address national
health problems. Among the discoveries made by KEMRI scientists that are fully
approved by relevant statutory national authorities include: KEMTAQ, an enzyme
for gene multiplication; KEMRAB, a hand sanitizer; HEPCELL Rapid, a Hepatitis B
surface antigen detection kit for laboratory diagnosis of Hepatis B virus
infection; KEMCOM Rapid, a rapid HIV1 and 2 detection kit among other. These
products have been tested and proven not only to be functional but relatively
less costly and should therefore be used by Kenyans instead of relying on
expensive imported similar products from overseas.
However,
when not properly regulated, the biological sciences research can be used for
non-peaceful purposes. For instance, the release of organisms causing smallpox,
plague, anthrax, influenza or other diseases could prove catastrophic in terms
of the resulting illnesses and deaths compounded by the panic such
outbreaks generate. The other reasons
that calls for regulation of biological sciences research include: the
potential for production of new microbial agents as expertise in biosciences
grows and methods for genetic manipulation of organisms become simpler. With
the threats caused by globalization and transport systems including increased
number of emerging and re-emerging diseases, the trans boundary spread of
infectious diseases, insecure transport and transfer of materials from sampling
sites during importation and exportation, inadequate laboratories to ensure bio-safety
and bio-security, there should be a legal framework in place to ensure that
dual-use research is prevented. The Government of Kenya, through Vision 2030,
recognizes the need to enhance biosecurity due to the growing threat of
biological agents that may be misused to cause devastating epidemics.
All
States Parties are expected to domesticate the convention. In Africa, Kenya is
miles ahead as far as the domestication of the convention is concerned.
Kenya
has prepared a draft Biosciences Policy and Biosciences Bill which has been
shared with stakeholders and policy makers. The country also developed
biotechnology awareness (BioAWARE) Strategy to inform stakeholders of the uses
of biotechnology; established National Biosafety Authority in 2009 to ensure
and assure safe application and use of genetically modified organisms (GMOs);
developed regulations on safe handling, use, import, export and transit of
GMOs; established Biotechnology institutions at the Kenya Medical Research
Institute, Kenyatta University, Kenya Agricultural Research Institute. However,
the country still needs to do more in terms of capacity building in
bioinformatics, disease surveillance, and nanotechnology and upgrading of
public laboratories to Biosafety Level 3. Enacting the Biosciences Policy and
Bill will therefore enhance domestication of the BTWC in the country in line
with requirements of the new Constitution that all treaties that Kenya has
ascended to must be part of the country’s Laws.
The
legal framework will also catalyze research in biological sciences for the
benefit of society. There is need to equally strengthen the basic sciences to
generate knowledge and contribute to global knowledge pool.